E Fund Management (HK)’s Terns Pharmaceuticals TERN Stock Holding History

E Fund Management (HK)’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-337	Closed	-$17.8K	–	563
2026 Q1	$17.8K	Buy	+337	New	+$13.8K	0.01%	219

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

E Fund Management (HK)'s TERN Position: Q2 2026 in Review

E Fund Management (HK) sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 337 shares — an estimated $17.8K sold.

E Fund Management (HK) first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $17.8K in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

E Fund Management (HK) reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
E Fund Management (HK) sold 337 Terns Pharmaceuticals shares in Q2 2026, an estimated $17.8K.
E Fund Management (HK) first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
E Fund Management (HK)'s Terns Pharmaceuticals position peaked at $17.8K in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on E Fund Management (HK)'s 13F filing for Q2 2026, filed 22 Jul 2026.